Tuesday, February 22, 2022

BANDHANBNK

BANDHANBNK

23.12.2022 - GS on BANDHANBNK Maintain Neutral CMP 239.7 Target 297
22.12.2022 - Jefferies on BANDHANBNK Maintain Buy CMP 234.25 Target 340
02.12.2022 - Motilal Oswal on BANDHANBNK Maintain Neutral CMP 246.7 Target 270
02.12.2022 - CLSA on BANDHANBNK Maintain Buy CMP 246.7 Target 300
10.10.2022 - CLSA on BANDHANBNK Maintain Outperform CMP 267.6 Target 325

06.09.2022 - Jefferies on BANDHANBNK Maintain Buy CMP 282.6 Target 400
11.07.2022 - Jefferies on BANDHANBNK Maintain Buy CMP 280.85 Target 430
21.06.2022 - Jefferies on BANDHANBNK Maintain Buy CMP 281.1 Target 430
17.05.2022 - Macquarie on BANDHANBNK Maintain Outperform CMP 338.45 Target 390
07.04.2022 - Jefferies on BANDHANBNK Maintain Buy CMP 315 Target 380
06.04.2022 - Jefferies on BANDHANBNK Maintain Buy CMP 315 Target 380
24.03.2022 - Jefferies on BANDHANBNK Maintain Buy CMP  303 Target 380
22.03.2022 - Macquarie on BANDHANBNK Maintain Neutral CMP 295 Target 320
15.03.2022 - CLSA on BANDHANBNK Upgrade Buy CMP 280 Target 340
24.02.2022 - Jefferies on BANDHANBNK Maintain Buy CMP 291.05 Target 380
23.02.2022 - CS on Bandhanbnk Maintain Outperform CMP 308 Target 360
24.01.2022 - CLSA on Bandhan Bank Maintain Outperform CMP 296 Target 340
24.01.2022 - Jefferies on Bandhan Bank Mantain Buy CMP 296 Target 380
05.01.2022  - CLSA Bandhan BK Maintain Sell CMP 254  Target 225
05.01.2022  - GS Bandhan BK Maintain Buy CMP 254  Target 440
05.01.2022  - GS Bandhan BK Maintain Buy Target 440

CS on Bandhan Bank : 30.08.2021

OP, TP Rs 370
MFI uncertainty weighing; strong core profitability &attractive vals 
Well capitalised, CET 1 at 24%, healthy deposit franchise (CASA at 43%) & strong PPoP RoA of > 6.5% as a result, even as credit costs remain elevated, RoEs  healthy

GS ON BANDHAN BANK : 03.08.2021

* GS maintains Buy rating on Bandhan Bank but removes it from the conviction list on near-term macro uncertainty
* Reported An Operationally Strong Quarter With PPOP 4% Ahead Of Estimates
* Growth & Most Importantly, Asset Quality Majorly Impacted Due To Strict Local Lockdowns
* Remain Buy, But Remove It From The Conviction List
* Near-term Macro Uncertainty Can Weigh On Stock Outperformance
* MAINTAIN BUY TARGET: 447

CLSA ON BANDHAN BANK : 16.07.2021

* CLSA shares its view on Bandhan Bank's Q1 update, says overdues in West Bengal have been high in spite of negligible political interference, maintains UNDERPERFORM rating on the stock
* Q1 Update Indicates Collection Efficiency Of 72% In Microfinance Biz Vs 95% Collections In March
* MFI Collections Drop Has Been High In COVID 2nd
* In West Bengal, Overdues High In Spite Of Negligible Political Interference
* MAINTAIN UNDERPERFORM TARGET: 300

JEFFERIES ON BANDHAN BANK : 21.06.2021

* MAINTAIN BUY TARGET: 400
* Jefferies maintains BUY call on Bandhan Bank, target at Rs 400/sh
* Assam govt Package Positive For Lenders
* Co Will Benefit As State Forms 12% Of MFI Loan & Faced Higher Stress
* FY22 May Still See 7% Negative Impact From Weaker Topline Due To Repayment
* Valuations Attractive At Current Levels

CLSA ON BANDHAN BANK : 21.06.2021

* MAINTAIN UNDERPERFORM TARGET: 300
* CLSA maintains UNDERPERFORM call on Bandhan Bank, target at Rs 300/sh
* Asaam Govt's MFI Pckg Should Provide Significant Relief
• This Package Will Be Credit Positive For Co's Assam Portfolio
• Impact Of The Second Wave Of COVID-19 Could Be Large
* Bengal Faced Collection Challenges Even Before The Second Wave

JEFFERIES ON BANDHAN BANK : 21.06.2021

* Maintain BUY, Target at Rs 400/share
• Assam's proposed MFI grant may clear overhang with small one-time impact
• Bandhan's valuation at 2.8x 12m forward ABV is attractive
• Assam is second largest state for Bandhan Bank
• State grant can address asset quality concern, but drag topline
* Large outgo for Assam may make other states desist in future

ERIS

ERIS(Eris Lifesciences Ltd) 18.01.2023 -  Macquarie  on  ERIS Maintain Outperform CMP 625.75 Target 830